4//SEC Filing
Gryaznov Sergei 4
Accession 0001127602-23-009775
CIK 0001878313other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 5:12 PM ET
Size
5.2 KB
Accession
0001127602-23-009775
Insider Transaction Report
Form 4
Gryaznov Sergei
Chief Scientific Officer
Transactions
- Award
Stock Options
2023-03-08+100,000→ 100,000 totalExercise: $4.10Exp: 2033-03-08→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913228
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 5:12 PM ET
- Size
- 5.2 KB